These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 19109042
1. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy. Scarpelli KC, Valladão ML, Metze K. Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042 [Abstract] [Full Text] [Related]
3. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs. Nak D, Nak Y, Cangul IT, Tuna B. J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105 [Abstract] [Full Text] [Related]
4. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation. Ferreira Bulhosa L, Estrela-Lima A, da Silva Solcà M, Diniz Gonçalves GS, Larangeira DF, de Pinho FA, Barrouin-Melo SM. Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469 [Abstract] [Full Text] [Related]
5. Chemotherapeutic management of transmissible venereal tumors in 30 dogs. Brown NO, Calvert C, MacEwen EG. J Am Vet Med Assoc; 1980 May 15; 176(10 Pt 1):983-6. PubMed ID: 7380719 [Abstract] [Full Text] [Related]
7. Semen quality during vincristine treatment in dogs with transmissible venereal tumor. Saratsis P, Ypsilantis P, Tselkas K. Theriogenology; 2000 Mar 15; 53(5):1185-92. PubMed ID: 10798495 [Abstract] [Full Text] [Related]
8. Vincristine for treatment of transmissible venereal tumor in the dog--. Calvert CA, Leifer CE, MacEwen EG. J Am Vet Med Assoc; 1982 Jul 15; 181(2):163-4. PubMed ID: 6749780 [No Abstract] [Full Text] [Related]
9. Transmissible venereal tumor: a retrospective study of 29 cases. Rogers KS, Walker MA, Dillon HB. J Am Anim Hosp Assoc; 1998 Jul 15; 34(6):463-70. PubMed ID: 9826280 [Abstract] [Full Text] [Related]
11. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour. Kanca H, Tez G, Bal K, Ozen D, Alcigir E, Atalay Vural S. Vet Med Sci; 2018 Nov 15; 4(4):364-372. PubMed ID: 30117719 [Abstract] [Full Text] [Related]
12. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT). Özalp GR, Zik B, Bastan A, Peker S, Özdemir-Salci ES, Bastan I, Darbaz I, Salar S, Karakas K. Biotech Histochem; 2012 Jul 15; 87(5):325-30. PubMed ID: 22404564 [Abstract] [Full Text] [Related]
18. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid. Pai CC, Kuo TF, Mao SJ, Chuang TF, Lin CS, Chu RM. Vet Immunol Immunopathol; 2011 Feb 15; 139(2-4):187-99. PubMed ID: 21051091 [Abstract] [Full Text] [Related]
19. Canine transmissible venereal tumour: a review. Ganguly B, Das U, Das AK. Vet Comp Oncol; 2016 Mar 15; 14(1):1-12. PubMed ID: 23981098 [Abstract] [Full Text] [Related]
20. Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2. DEN Otter W, Hack M, Jacobs JJ, Tan JF, Rozendaal L, VAN Moorselaar RJ. Anticancer Res; 2015 Jun 15; 35(6):3385-91. PubMed ID: 26026099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]